Skip to main content
Top
Published in: Neurological Sciences 9/2019

01-09-2019 | Angiography | Letter to the Editor

Posterior reversible encephalopathy syndrome overlapping contrast-induced encephalopathy after coronary angiography

Authors: Arturo de Falco, Marta De Simone, Florindo d’Onofrio, Daniele Spitaleri, Fabrizio Antonio de Falco

Published in: Neurological Sciences | Issue 9/2019

Login to get access

Excerpt

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological disorder characterised by acute-onset neurological symptoms (typically seizures, encephalopathy, headache and visual disturbances) and reversible subcortical vasogenic brain oedema related to heterogeneous aetiologies. Brain imaging usually reveals vasogenic oedema predominantly involving the parieto-occipital regions. PRES is generally reversible, both radiologically and clinically [1]. On the other hand, contrast-induced encephalopathy (CE) has been described as a rare complication of angiography. It was first reported in 1970 as a transient cortical blindness and focal neurological deficits after coronary angiography (CAG) [2]. Clinical effects of neurotoxicity from iodinated contrast agents include visual fields defects, encephalopathy, seizures and focal neurological deficits. Also, CE is extensively reported to have a benign clinical course [2]. The reported incidence is 0.06% of patients undergoing CAG, 0.3–1% of patients undergoing vertebral angioplasty and 2.9% with endovascular coil treatment of posterior circulation aneurysm [2]. As already supposed, there is a clinical and neuroradiological overlap between the two syndromes [3]. Here, we report a case of typical PRES following CAG, and we discuss the pathophysiological overlap with CE. …
Literature
1.
go back to reference Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–925CrossRefPubMed Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–925CrossRefPubMed
2.
go back to reference Leong S, Fanning NF (2012) Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. a case report and review of the literature. Interv Neuroradiol 18:33–41CrossRefPubMedPubMedCentral Leong S, Fanning NF (2012) Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. a case report and review of the literature. Interv Neuroradiol 18:33–41CrossRefPubMedPubMedCentral
3.
go back to reference Saigal G, Bhatia R, Bhatia S, Wakhloo AKMR (2004) Findings of cortical blindness following cerebral angiography: is this entity related to posterior reversible leukoencephalopathy. Am J Neuroradiol 25:252–256PubMedPubMedCentral Saigal G, Bhatia R, Bhatia S, Wakhloo AKMR (2004) Findings of cortical blindness following cerebral angiography: is this entity related to posterior reversible leukoencephalopathy. Am J Neuroradiol 25:252–256PubMedPubMedCentral
4.
go back to reference Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E, Magliulo G (2015) Posterior reversible encephalopathy syndrome--insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 14(9):830–836CrossRefPubMed Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E, Magliulo G (2015) Posterior reversible encephalopathy syndrome--insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 14(9):830–836CrossRefPubMed
5.
go back to reference Ulas T, Buyukhatipoglu H, Dal MS, Kirhan I, Kaya Z, Demir ME, Tursun I, Eren MA, Aydogan T, Sezen Y, Aksoy N (2013) Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 18(3):205–209 Ulas T, Buyukhatipoglu H, Dal MS, Kirhan I, Kaya Z, Demir ME, Tursun I, Eren MA, Aydogan T, Sezen Y, Aksoy N (2013) Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 18(3):205–209
6.
go back to reference Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10(7):618–625CrossRefPubMed Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10(7):618–625CrossRefPubMed
Metadata
Title
Posterior reversible encephalopathy syndrome overlapping contrast-induced encephalopathy after coronary angiography
Authors
Arturo de Falco
Marta De Simone
Florindo d’Onofrio
Daniele Spitaleri
Fabrizio Antonio de Falco
Publication date
01-09-2019
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03810-w

Other articles of this Issue 9/2019

Neurological Sciences 9/2019 Go to the issue